4//SEC Filing
Huang Qingxi 4
Accession 0001683168-19-002124
CIK 0001516079other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:13 PM ET
Size
8.1 KB
Accession
0001683168-19-002124
Insider Transaction Report
Form 4
Huang Qingxi
Director
Transactions
- Purchase
Warrant
2019-05-29$0.05/sh+10,725,000$536,250→ 10,725,000 total(indirect: See footnote)Exercise: $0.05From: 2019-05-24Exp: 2020-11-24→ Common Stock (10,725,000 underlying) - Purchase
Common Stock
2019-05-29$214500.00/sh+4,290,000$920,205,000,000→ 12,422,000 total(indirect: See footnote)
Footnotes (2)
- [F1]On May 29, 2019, China Israel Biotechnology Co. Ltd. ("CIB"), a Chinese corporation, of which Mr. Huang is a controlling officer and director of, acquired 4,290,000 units at purchase price of $0.05 per share. Each single Unit consists of one (1) share of common stock of the Company and two and one half (2.5) warrants (collectively the "Units"), which shall be exercisable for 18 months at $0.05 per share (the "Warrants").
- [F2]Mr. Huangs beneficial ownership includes 10,922,000 shares held by CIB and 1,500,000 shares held by Central Bio-MD Valley Technology Co., Ltd. ("CBV"), a Chinese corporation. Mr. Huang is a controlling officer and director of CIB and CBV and has voting and dispositive control over the shares.
Documents
Issuer
US-China Biomedical Technology, Inc.
CIK 0001516079
Entity typeother
Related Parties
1- filerCIK 0001713489
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:13 PM ET
- Size
- 8.1 KB